Next Generation News and Research

RSS

GE announces 510k clearance for wireless, digital X-ray detector at 96th RSNA

GE Healthcare announced today the 510k clearance of its next generation wireless, digital X-ray detector at the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago. GE's FlashPad is a reliable, long-term investment for future Radiography and Fluoroscopy systems, compatible with a variety of GE X-ray products today and is the only wireless digital detector capable of supporting advanced applications.

30 Nov 2010

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

Life Technologies Corporation, a provider of innovative life science solutions, today announced the launch of its next-generation Qubit® 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that require a large financial or time investment. The new system quantitates DNA, RNA and protein with accuracy, sensitivity, speed and ease-of-use.

29 Nov 2010

E. coli host bacterium produces antibiotic erythromycin A

Researchers at Tufts University School of Engineering have reported the first successful production of the antibiotic erythromycin A, and two variations, using E. coli as the production host.

24 Nov 2010

Dr. Yves DeClerck honored as first recipient of Richard Call Family Endowed Chair

Yves A. DeClerck, MD, professor of Pediatrics, Biochemistry and Molecular Biology at the Keck School of Medicine of the University of Southern California, has been inducted as the inaugural holder of the Richard Call Family Endowed Chair in Pediatric Research Innovation.

24 Nov 2010

Medicalis to showcase Radiology Collaborative Workflow Solutions at 96th RSNA

Medicalis today announced the commercialization of its next generation Radiology Collaborative Workflow Solutions™ offering providers a sophisticated technology platform to enhance productivity and ensure the delivery of measureable high-quality radiology care. For the first time, the company will showcase its three groundbreaking Collaborative Workflow Solutions at the 96th annual meeting of the Radiological Society of North America (RSNA), Nov. 28 – Dec. 2, in Chicago (Booth 4050).

23 Nov 2010

Mother’s high-fat diet alters fetal genes that regulate circadian rhythm: Study

The link between sleeping and obesity is drawn tighter as a new research published online in the FASEB Journal study shows that what your mother ate when she was pregnant may make you obese or overweight by altering the function of genes (epigenetic changes) that regulate circadian rhythm.

23 Nov 2010

Confidisc introduces new anti-illegal drug syringe

ConfiDisc's anti-illegal drug syringe is an integral part of its syringe injection system. The disc, which is attached to the hub of a syringe device, acts as a physical barrier.

22 Nov 2010

ImmunGene awarded $244,479 therapeutic discovery project grant under PPACA 2010

ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.

22 Nov 2010

Eastern Virginia professor says average doctor may be toting new pocket-sized ultrasound machine

Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.

20 Nov 2010

Removal of tobacco displays changes young people's attitude to smoking

Putting tobacco out of sight in shops not only changes young people's attitude to smoking but doesn't result in retailers losing money - according to new research published in Tobacco Control today (Friday).

20 Nov 2010

Boston Scientific's CRT-Ds, ICDs receive CE Mark approval

Boston Scientific Corporation today announced CE Mark approval of its INCEPTA, ENERGEN and PUNCTUA cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators.

19 Nov 2010

Elorac announces results of Phase III CPO solution studies for acne at Healthcare Conference in New York

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced results of two Phase III studies of its patented Carbamide Peroxide (CPO) solution for the treatment of inflammatory acne vulgaris and rosacea at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.

19 Nov 2010

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the presentation of data in two poster presentations at the 22nd EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics," held in Berlin, Germany, November 16-19.

19 Nov 2010

NTU to develop Five Peaks of Excellence under 5-year strategic plan

Nanyang Technological University (NTU) today unveiled NTU 2015, a five-year strategic plan that maps out how the university will become a great global university by 2015. Under this blueprint, NTU will build on its current strengths and heritage to make its mark globally in sustainability, healthcare, new media, the best of the East and West, and innovation.

18 Nov 2010

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.

18 Nov 2010

Siemens launches MAMMOMAT Inspiration Full-Field Digital Mammography System in the U.S.

Siemens announces that the MAMMOMAT® Inspiration Full-Field Digital Mammography System is now commercially available in the United States. The MAMMOMAT Inspiration offers digital screening and diagnostic mammography, stereotactic biopsy, and upgrade capability to future technologies all in one system.

17 Nov 2010

Aeterna Zentaris presents results of orally active compounds with anti-tumor effects at EORTC-NCI-AACR Symposium

Aeterna Zentaris Inc. today presented posters on encouraging preclinical results for AEZS-129 and AEZS-132, two novel orally active compounds with anti-tumor effects.

17 Nov 2010

Cardio3 BioSciences announces positive results from C-Cure Phase II clinical trial for heart failure

The Belgian biotechnology company, Cardio3 BioSciences a leader in discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases today announces positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure(R), designed as a novel stem cell therapy for heart failure based on breakthrough technology.

17 Nov 2010

Agilent introduces OpenLAB chromatography data system

Agilent Technologies Inc. today introduced Agilent OpenLAB CDS, the next-generation chromatography data system (CDS) of Agilent's market-leading ChemStation and EZChrom Elite CDS platforms. OpenLAB CDS is designed on the modern and fully scalable OpenLAB Shared Services architecture. This provides major feature improvements to current ChemStation and EZChrom Elite platforms.

17 Nov 2010

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

HealthCare Insight (HCI) today unveiled Nucleus™, a next-generation technology platform for fraud, waste, and abuse prevention and detection, at the Annual Training Conference & Anti-Fraud Expo of the National Healthcare Anti-Fraud Association (NHCAA). The Nucleus application features advanced analytics, comprehensive risk scoring, and a customizable interface to help insurers stop fraud before medical claims are paid.

17 Nov 2010

Next Generation News and Research

GE announces 510k clearance for wireless, digital X-ray detector at 96th RSNA

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

E. coli host bacterium produces antibiotic erythromycin A

Dr. Yves DeClerck honored as first recipient of Richard Call Family Endowed Chair

Medicalis to showcase Radiology Collaborative Workflow Solutions at 96th RSNA

Mother’s high-fat diet alters fetal genes that regulate circadian rhythm: Study

Confidisc introduces new anti-illegal drug syringe

ImmunGene awarded $244,479 therapeutic discovery project grant under PPACA 2010

Eastern Virginia professor says average doctor may be toting new pocket-sized ultrasound machine

Removal of tobacco displays changes young people's attitude to smoking

Boston Scientific's CRT-Ds, ICDs receive CE Mark approval

Elorac announces results of Phase III CPO solution studies for acne at Healthcare Conference in New York

Clinical data of CU-201, CUDC-101 presented at EORTC-NCI-AACR Symposium

NTU to develop Five Peaks of Excellence under 5-year strategic plan

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Siemens launches MAMMOMAT Inspiration Full-Field Digital Mammography System in the U.S.

Aeterna Zentaris presents results of orally active compounds with anti-tumor effects at EORTC-NCI-AACR Symposium

Cardio3 BioSciences announces positive results from C-Cure Phase II clinical trial for heart failure

Agilent introduces OpenLAB chromatography data system

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News